HOME ȸ»ç¼Ò°³ ½ÃÀÛÆäÀÌÁö·Î Áñ°Üã±âÃß°¡ ±âÀÚȸ¿ø½Åû
[¸ð¹ÙÀϸðµå] ·Î±×ÀΠȸ¿ø°¡ÀÔ
2024³â05¿ù19ÀÏsun
±â»çÃÖÁ¾ÆíÁýÀÏ: 2024-05-17 18:58:28
´º½ºÈ¨ > ±â°ü/´Üü > KDIHI
2010³â08¿ù26ÀÏ 00½Ã00ºÐ
±ÛÀÚÅ©±â ±â»ç³»¿ë À̸ÞÀϺ¸³»±â ´º½ºÇÁ¸°Æ®Çϱ⠴º½º½ºÅ©·¦Çϱâ
ÁøÈï¿ø, ±Û·Î¹ú ±â¼ú»ç¾÷È­ Àü¹®°¡ ¾ç¼º ¾ÕÀå
½Å¾àÁ¶ÇÕ°ú °øµ¿ ¡®Entrepreneurship Boot Camp 2010¡¯°³ÃÖ

Çѱ¹º¸°Ç»ê¾÷ÁøÈï¿ø(¿øÀå ±è¹ý¿Ï)ÀÌ ¹ÙÀÌ¿ÀÄÚ¸®¾Æ Çà»ç¸¦ ÅëÇØ ±Û·Î¹ú ±â¼ú»ç¾÷È­ Àü¹®°¡ ¾ç¼º¿¡ ¾ÕÀå¼±´Ù.

ÁøÈï¿øÀº Çѱ¹½Å¾à°³¹ß¿¬±¸Á¶ÇÕ(ÀÌ»çÀå Á¶ÀÇȯ)°ú °øµ¿À¸·Î ¿À´Â 8¿ù 31ÀÏ(È­) ¼¶À¯¼¾ÅÍ 17Ãþ ´ëȸÀǽǿ¡¼­ ¹ÙÀÌ¿ÀÄÚ¸®¾Æ 2010 ÄÁÆÛ·±½º&Àü½ÃȸÀÇ °ø½Ä ºÎ´ëÇà»ç·Î 'The Entrepreneurship Boot Camp 2010'À» °³ÃÖÇÑ´Ù°í ¹àÇû´Ù.

À̹ø Çà»ç´Â ¹Ì±¹ BIO ±¹Á¦Çà»ç¿¡¼­ 6ȸ° °³ÃÖÇÏ°í ÀÖ´Â ¹ÙÀÌ¿À±â¾÷´ë»ó Àü¹®±³À°ÇÁ·Î±×·¥À¸·Î ¾Æ½Ã¾Æ¿¡¼­´Â Áö³­ 2009³â¿¡ ÀÌ¾î µÎ ¹ø°·Î ¿­¸®´Â °ÍÀÌ´Ù. µ¿ ±³À°ÇÁ·Î±×·¥¿¡´Â Á¦¾à ¹× ¹ÙÀÌ¿À±â¾÷ÀÇ ½Ç¹«ÀÚ¿¡°Ô Àü·«»ç¾÷À¸·Î Àνĵǰí ÀÖ´Â Patent Strategy, Licensing Agreement, Deal Structure, Technology Valuation & Evaluation¿¡ ´ëÇÑ ¾÷¹« ³ëÇÏ¿ì¿Í ±â¾÷ÀÇ Çù»ó´É·ÂÀ» Á¦°íÇÏ°íÀÚ, ±â¼ú¶óÀ̼¾½Ì, ÅõÀÚ, Áö½ÄÀç»ê±Ç ºÐ¾ß Àü¹®¼º°ú ´Ù³â°£ÀÇ °æÇèÀ» º¸À¯ÇÏ°í ÀÖ´Â ±¹³»¿Ü ÃÖ°íÀÇ Àü¹®°¡µéÀ» ÃʺùÇÏ¿© ÃÑ 4°³ ¼¼¼Ç¿¡ °ÉÃÄ ±³À°À» ÁøÇàÇÑ´Ù.

ÁÖ¿ä ÁÂÀå ¹× ¿¬»ç·Î´Â Çѱ¹MSDÀÇ °úÇб³·ù´ë»çÀÎ ±è±ÔÂù ¹Ú»ç, ¹Ì±¹ ±¹¸³º¸°Ç¿ø(NIH)ÀÇ ±â¼úÀÌÀü ¹× ¶óÀ̼¾½Ì Àü¹®°¡ÀÎ Cristina ¹Ú»ç, ƯÇãûÀÇ »ý¸í°øÇРƯÇãºÐ¾ßÀÇ ¿À·£ Àü¹®°¡ÀÎ Á¶¸í¼± °úÀå, Burrill&CompanyÀÇ Michael Keyoung, ±â¼ú¶óÀ̼¾½Ì ºÐ¾ß¿¡¼­ Ź¿ùÇÑ ³ëÇϿ츦 º¸À¯ÇÑ IPRONTIERÀÇ ³ëÁöÁØ º¯È£»ç, ´ëÇü ·ÎÆßÀÎ ¹ý¹«¹ýÀÎ ÅÂÆò¾çÀÇ ÀÌÀº°æ º¯¸®»ç, ¹ÙÀÌ¿À ¹× º¸°ÇÀÇ·á Àü·« ÀÚ¹®È¸»çÀÎ SDS GroupÀÇ ±èÅÂÈ£ ´ëÇ¥ µîÀÌ Âü°¡ÇÒ ¿¹Á¤ÀÌ´Ù.

ÁÖ¿ä ±³À°³»¿ëÀº »ý¸í°øÇÐ ±â¾÷ÀÇ Æ¯Çã°ü¸®¸¦ À§ÇÑ À¯ÀüÀÚ Æ¯ÇãÀ̽´¿Í ´ëÀÀ Àü·«, ÀÌ¿¡ µû¸¥ ƯÇã ºÐÀï ¹× ¼Ò¼Û »ç·Ê, ±â¾÷ÀÇ ±â¼ú ÀÌÀü Çù»ó °úÁ¤¿¡¼­ ÇÊ¿¬ÀûÀ¸·Î »ç¿ëµÇ´Â Agreement ¼­½ÄÀÎ CDA(Confidentiality Disclosure Agreement), MTA(Material Transfer Agreement), Licensing Agreement, Clinical Trial Agreement¿¡ ´ëÇÑ ³»¿ëÀÌ ´Ù·ç¾îÁú ¿¹Á¤ÀÌ´Ù.

À̹ø Çà»çÀÇ Âü°¡´ë»óÀº ±¹³» Á¦¾à ¹× ¹ÙÀÌ¿À °ü·Ã ±â¾÷ÀÇ ´ëÇ¥, ¿¬±¸¼Ò °ü°èÀÚ ¹× ±â¼ú»ç¾÷ ´ã´çÀÚÀ̸ç, www.biokorea.org¿¡¼­ ÀÚ¼¼ÇÑ ¾È³»¿Í ÇÔ²² Âü°¡ ½ÅûÇÒ ¼ö ÀÖ´Ù.

 

 

°ü·Ã±â»ç°¡ ¾ø½À´Ï´Ù
´º½º½ºÅ©·¦Çϱâ
°­µ¿Áø (djkangdj@hanmail.net) ±âÀÚ 
À̱âÀÚÀÇ ´Ù¸¥´º½ºº¸±â
KDIHI¼½¼Ç ¸ñ·ÏÀ¸·Î
°Çº¸°ø´Ü, °³Àμº°ú°è¾à ü...
ÁøÈï¿ø, Ãß¼® ¸Â¾Æ Á¶Ä¡¿ø...
ÁøÈï¿ø, ¼­¿ï½Ã Çб³º¸°ÇÁø...
ÁøÈï¿ø, ¼­¿ï´ëº´¿ø°ú Ä«ÀÚ...
¾Æ½Ã¾Æ ´ëÇ¥ ±Û·Î¹úÇコÄÉ...
´ÙÀ½±â»ç : ÁøÈï¿ø, 9¿ù 7ÀÏ º¸°Ç»ê¾÷ÁøÈïÆ÷·³ °³ÃÖ (2010-09-01 00:00:00)
ÀÌÀü±â»ç : ¹ÙÀÌ¿ÀÄÚ¸®¾Æ 2010, 9¿ù1ÀϺÎÅÍ 3ÀÏ°£ ÄÚ¿¢½º¼­ °³¸· (2010-08-09 00:00:00)
º´¿ø°è, "°è...
º´¿ø°è, "°è¹¦³â...
Á¦¾à¡¤°Ç½Ä 12°³...
´ë¿õÁ¦¾à, ¿Ã »ó¹Ý±â '¿µ¾÷ ºÎ...
º¸·É, ¿ÃÇØ »ó¹Ý±â '¿µ¾÷Á÷ ½Å...
°Çº¸°ø´Ü, ¼Ò¼Ó±â°ü '¼­¿ï¿ä¾ç...
¼ºÀåÇÏ°íÇ ´ç½Å, "Áö±Ý ´ë¿õ,...
º¸·ÉÁ¦¾à, ¿Ã »ó¹Ý±â '¿µ¾÷Á÷ ...
³í¹®) Airway epithelial CD47 plays a critical role
ȸ»ç¼Ò°³ °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ ÀÌ¿ë¾à°ü À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ ¾Ë¸³´Ï´Ù º¸µµÀÚ·á ±â»çÁ¦º¸ Á¤±â±¸µ¶